Answer Summary

Members shared mixed experiences about driving to and from chemotherapy with Bendamustine and Rituxan, with the strongest consensus being that... Read more

Members shared mixed experiences about driving to and from chemotherapy with Bendamustine and Rituxan, with the strongest consensus being that someone else should drive after the first treatment to assess how the body responds to pre-medications like Benadryl, which often causes drowsiness. Several members described being able to drive themselves after the initial infusion once they knew how their body reacted, though many emphasized the value of having support, especially on longer treatment days that can stretch beyond six hours due to slower infusion rates or unexpected reactions. A recurring theme was the importance of listening to your body, immediately alerting nurses to any unusual symptoms, and accepting help when available, with some mentioning volunteer driver programs through organizations like the Cancer Society.